Tiziana Life Sciences TLSA
NASDAQ TLSA
$0.62 +0.01 (+1.77%)
At close: Nov 11, 2026 · 4:00 PM EST

Tiziana Life Sciences (TLSA) Receivables (2017 - 2022)

Updated

Tiziana Life Sciences (TLSA) recorded Receivables of $4.85 million in Q4 2022, up 175.8% from $1.76 million a year earlier.

Analysis

Tiziana Life Sciences (TLSA) Receivables (2017 - 2022) Analysis & Trends

Starting with Q4 2017, Tiziana Life Sciences' Receivables history includes 6 quarters.

  • Annual Receivables has increased for three straight years, with a five-year compound annual growth rate of 14.2% (FY2017 to FY2022).
  • Across earlier years, Receivables came in at $1.76 million in FY2021 (+52.4%), $1.15 million in FY2020 (+285.6%), $299,000 in FY2019 (-77.3%) and $1.32 million in FY2018 (-47.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 Tiziana Life Sciences 73.51 Mn 55.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4.85 Mn
Dec 31, 2021 1.76 Mn
Dec 31, 2020 1.15 Mn
Dec 31, 2019 299,000.00
Dec 31, 2018 1.32 Mn
Dec 31, 2017 2.49 Mn
API Access

Tiziana Life Sciences Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=TLSA&period=max&api_key=YOUR_API_KEY